Retraction: Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis
Sections
Open Access Retraction
Retraction: Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis

Explor Neuroprot Ther. 2023;3:513 DOl: https://doi.org/10.37349/ent.2023.00066

Received: Accepted: Published: December 29, 2023

Retraction to “Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis” by Saito Y. Explor Neuroprot Ther. 2023;3:186–206. DOI: 10.37349/ent.2023.00047

The original article was retracted by the Journal due to excessive unreferenced overlapping of text and similarity in Figures with another previously published article [1].

This retraction was approved by the Editor-in-Chief.

The publisher regrets that this issue was not identified by the usual quality checks before publication and plans to take additional measures to safeguard research integrity.

References

Kamagata K, Andica C, Kato A, Saito Y, Uchida W, Hatano T, et al. Diffusion magnetic resonance imaging-based biomarkers for neurodegenerative diseases. Int J Mol Sci. 2021;22:5216. [DOI] [PubMed] [PMC]
Cite this Article
Export Citation
Editorial Office. Retraction: Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis. Explor Neuroprot Ther. 2023;3:513. https://doi.org/10.37349/ent.2023.00066
Article Metrics

View: 913

Download: 34

Times Cited: 0